http://www.fpnotebook.com/
Blood DopingAka: Blood Boosting
- Techniques
- Blood doping (blood boosting)
- pRBC Units donated well before an event
- pRBC transfused immediately before an event
- Recombinent Erythropoietin (rEPO)
- Stimulates red cell mass
- Very expensive
- Same effect as blood doping
- Blood doping (blood boosting)
- Adverse Effects
- Hypercoagulation risk may be fatal
- Deep Vein Thrombosis
- Pulmonary Embolism
- Cerebrovascular Accident
- Myocardial Infarction
- Eighteen deaths by European Cyclists who blood doped
- Transfusion reaction
- Bloodbourne infection (including HIV)
- Hypercoagulation risk may be fatal
- Efficacy
- Increases performance in endurance sports (e.g. long-distance cycling)
- Detection
- Not detected, but banned by olympic committee 1984
Recombinant Erythropoietin (C0376541) | |
|---|---|
| Definition (MSH) | ERYTHROPOIETIN prepared by recombinant DNA technology. |
| Definition (NCI) | A recombinant therapeutic agent which is chemically identical to or similar to the endogenous glycoprotein erythropoietin (Epo). Epo promotes the differentiation and maturation of hematopoietic progenitors into erythrocytes; is a mitogen and a chemoattractant for endothelial cells; stimulates activated and differentiated B-cells and enhances B-cell immunoglobulin production and proliferation; and is hypoxia-inducible. (NCI04) |
| Concepts | Amino Acid, Peptide, or Protein (T116) , Pharmacologic Substance (T121) |
| MSH | D019321 |
| English | Erythrocyte Colony Stimulating Factor, Erythropoietin, Hematopoietin, r-HuEPO, Recombinant EPO, Recombinant Erythropoietin |
| Parent Concepts | Erythropoietin (C0014822), Recombinant Proteins (C0034861), Miscellaneous Chemoprotective Agent (C1513327), Recombinant Hematopoietic Growth Factor (C1515378) |
| Sources | MSH, MTH, NCI, NDFRT, PDQ Derived from the NIH UMLS (Unified Medical Language System) |
